Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Adenocarcinoma × pasireotide × Clear all

Sponsor

Conditions

Pituitary Neoplasms 4 Prostatic Neoplasms 3 Pituitary ACTH Hypersecretion 2 Pancreatic Neoplasms 2 Neuroendocrine Tumors 2 Neoplasms 2 Carcinoid Tumor 2 Acromegaly 2 Uveal Melanoma 1 Thyroid Neoplasms 1 Serotonin Syndrome 1 Prolactinoma 1 Primary Inoperable Thymoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neuroectodermal Tumors, Primitive 1 Neoplasm Metastasis 1 Nelson Syndrome 1 Myelodysplastic Syndromes 1 Meningioma 1 Melanoma 1 Lymphoma 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Hematologic Neoplasms 1 Growth Disorders 1 Gigantism 1 Gastro-enteropancreatic neuroendocrine tumor 1 Dumping Syndrome 1 Carcinoma, Neuroendocrine 1 Carcinoma, Hepatocellular 1

Interventions

Gemcitabine 11 Cisplatin 11 Capecitabine 11 Oxaliplatin 9 Fluorouracil 9 130-nm albumin-bound paclitaxel 8 pembrolizumab 7 Paclitaxel 7 Ramucirumab 6 Leucovorin 6 Carboplatin 6 Bevacizumab 6 Pemetrexed 4 Nivolumab 4 Irinotecan 4 Everolimus 4 Erlotinib Hydrochloride 4 Docetaxel 4 Cyclophosphamide 4 Albumin-Bound Paclitaxel 4 trastuzumab deruxtecan 3 Radiotherapy 3 Afatinib 3 zolbetuximab 2 pralsetinib 2 cabozantinib 2 Trastuzumab 2 Ipilimumab 2 vosaroxin 1 vandetanib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡